NSE filing, NSE: WANBURY. Summary written from the filing by ALFA Finder's alert engine.
Wanbury Ltd: key numbers
- Share price
- ₹199.10
- Market cap
- ₹696.2 Cr
- Revenue (annual)
- ₹650.3 Cr
- Net profit (annual)
- ₹66.13 Cr
- P/E (TTM)
- 13.2×Sector 42.0×
- Promoter holding
- 42.98%-0.04% QoQ
- FII holding
- 0.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wanbury Ltd
All →Wanbury Q2 FY27 Results: Net Profit ₹11.9 Cr, Down 21.7% YoY
Wanbury Ltd reported revenue from operations of ₹182.9 Cr (+14.2% YoY) and net profit of ₹11.9 Cr (-21.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.9 Cr · -21.7% YoY
Wanbury Business Update
Wanbury's Tanuku plant received an Australian TGA GMP certificate covering six APIs. This strengthens the company's global pharmaceutical manufacturing credentials.
Wanbury Board Meeting Date
Wanbury Limited has scheduled its Board Meeting for 4 Nov 2026 to consider unaudited half-year results. No financial figures or material decisions are disclosed in this advance intimation.
Wanbury Other Announcement
Wanbury Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI listing regulations.
Wanbury Business Update
Wanbury Limited received nine "No DMF Deficiency" letters from the USFDA for Metformin HCl. The company also expanded its business in Saudi Arabia and Mexico with an annual revenue potential of Rs 25 Crore.
Wanbury Product Launch
Wanbury Skin Health launched its berrysoft baby product range across multiple Indian states. This marks the company's strategic entry into the paediatric dermatology segment.
Other employee stock options announcements
All →Piramal Finance Employee Stock Options
Piramal Finance allotted 6,00,000 equity shares to its ESOP Trust under the 2025 employee scheme. Paid-up share capital rises to Rs 47,44,60,612 across 23,72,30,306 shares.
Prime Fresh Employee Stock Options
Prime Fresh's Nomination and Remuneration Committee granted 86,850 stock options to eligible employees under its 2024 ESOP plan. The options vest after one year, with no exercise price or cash proceeds disclosed.
- Execution
- 01 year vesting from date of grant; exercisable within one year after vesting completion
HCP Plastene Bulkpack Employee Stock Options
HCP Plastene Bulkpack granted 140,100 ESOP options to eligible employees under its ESOP Scheme 2022. Each option converts into one ₹10 equity share on vesting and exercise.
NOCIL Employee Stock Options
NOCIL allotted 18,150 equity shares to senior management on exercising 2017 stock options at Rs 84.05 each. Paid-up capital rises to Rs 167.04 Crore.
Honasa Consumer Employee Stock Options
Honasa Consumer's board granted 1,61,700 stock options to eligible employees under its ESOP 2018 plan at Rs 10 exercise price. The grant is an employee stock option event with no cash proceeds recorded yet.
IDFC First Bank Employee Stock Options
IDFC FIRST Bank allotted 35,45,636 equity shares to employees on exercise of ESOS options, raising paid-up capital to ₹86,28,37,12,890. No cash consideration figure is disclosed in the filing.